Hanzel J, Jansen JM, Ter Steege RWF, Gecse KB, et al. Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study. Inflamm Bowel Dis 2021 May 20. pii: 6278840. doi: 10.1093.
PMID: 34013959